Postoperative adjuvant lapatinib and concurrent chemoradiotherapy followed by maintenance lapatinib monotherapy in high-risk patients with resected squamous cell carcinoma of the head and neck: A Phase III, randomized, double-blind, placebo-controlled study. In Onkológia. ISSN 1336-8176. Bratislava : SOLEN, 2015, 2015, roč. 10, č. 6, s. 403.